Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03628716
Title CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bavarian Nordic
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa Florida 33612 United States Details
Norton Cancer Institute, Norton Healthcare Pavilion Louisville Kentucky 40202 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute (DFCI) Boston Massachusetts 02215 United States Details
University of Utah - Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field